Fri, 21 Nov 2014 01:00:00 +0100 Sanofi.com: Last press releases Press releases and press packs are intended to journalists, investors and shareholders. /rss/rss.asp <![CDATA[European CHMP Adopts Positive Opinion for Genzyme’s Cerdelga® (eliglustat) Capsules]]> Fri, 21 Nov 2014 01:00:00 +0100 http://en.sanofi.com/Images/37661_20141121_cerdelga_en.pdf <![CDATA[Sanofi and Regeneron Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis]]> Thu, 20 Nov 2014 07:30:00 +0100 http://en.sanofi.com/Images/37639_20141120_Dupilumab_AD_Breakthrough_2_en.pdf <![CDATA[Sanofi Outlines Next Wave of Innovative Medicines and Vaccines]]> Thu, 20 Nov 2014 07:00:00 +0100 http://en.sanofi.com/Images/37642_20141120_3_New_Medicines_Day_en.pdf <![CDATA[Sanofi and Regeneron Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol]]> Wed, 19 Nov 2014 02:15:00 +0100 http://en.sanofi.com/Images/37627_20141118_alirocumab_en.pdf <![CDATA[Sanofi nominates Professor Bonnie L. Bassler to its Board of Directors]]> Tue, 18 Nov 2014 01:15:00 +0100 http://en.sanofi.com/Images/37617_20141118_BODNomination_EN.pdf <![CDATA[Sanofi Names Chief Scientific Officer Gary Nabel as Sanofi Ebola Response Coordinator]]> Tue, 18 Nov 2014 07:00:00 +0100 http://en.sanofi.com/Images/37608_20141118_Nabel-Ebola_en.pdf <![CDATA[Genzyme’s Lemtrada Approved by the FDA]]> Sat, 15 Nov 2014 03:00:00 +0100 http://en.sanofi.com/Images/37587_20141115_LemtradaApprovedFDA_en.pdf <![CDATA[Sanofi and the Institut Pasteur reward four researchers for their influential work in the life sciences]]> Thu, 13 Nov 2014 07:00:00 +0100 http://en.sanofi.com/Images/37579_20141113_Prix_Sanofi_Institut_Pasteur_EN.pdf <![CDATA[Sanofi and Regeneron Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma]]> Tue, 11 Nov 2014 07:00:00 +0100 http://en.sanofi.com/Images/37564_20141111_Dupilumab_en.pdf <![CDATA[The New England Journal of Medicine Publishes Results of Final Landmark Phase III Efficacy Clinical Study of Sanofi Pasteur’s Dengue Vaccine Candidate]]> Mon, 03 Nov 2014 08:45:00 +0100 http://en.sanofi.com/Images/37528_20141103_dengue_2_en.pdf 5 © Sanofi 2004-2014